
BioHarvest Sciences Inc. (OTCPK: CNVCF) (CSE:BHSC) (FSE:8MV) announced a financing plan based on a private placement of up to $5 million. The funds raised will allow the company to accelerate the growth plan for its polyphenols/antioxidants and cannabis verticals.
On March 23, 2021, BHSC announced the completion of the company's cannabis R&D program, marking the start of the proposed transition to commercial-scale manufacturing. BioHarvest plans to bring its first cannabis products to market in 2022 and will be converting the current VINIA 2 tons/year facility in Rehovot, Israel to produce cannabis.